98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.healun.2025.01.003 | DOI Listing |
Pediatr Crit Care Med
September 2025
Department of Cardiac, Respiratory and Critical Care, Evelina London Children's Hospital, London, United Kingdom.
Objectives: To identify factors associated with death, requirement for extracorporeal membrane oxygenation (ECMO), or cardiac intervention in neonates referred for higher level neonatal ICU (NICU) due to respiratory failure.
Design: Retrospective cohort study, 2018-2020.
Setting: Referrals for transport to tertiary-level NICUs using the London Neonatal Transfer Service in the United Kingdom.
Front Pharmacol
August 2025
Warszawski Uniwersytet Medyczny, Warsaw, Poland.
Objective: The study aimed to analyse purchasing trends of pharmacological products used in allergy management based on data from in-person pharmacy sales across Poland.
Materials And Methods: The research involved an analysis of the sales of pharmacological agents used to alleviate symptoms of localized and systemic allergic skin reactions. The data were collected from a nationwide sample of 6,500 brick-and-mortar pharmacies over the period from 2020 to 2023.
ACS Omega
September 2025
Changsha Research Institute of Mining and Metallurgy CO., LTD, Changsha 410012, Hunan, China.
The long-term accumulation of electrolytic manganese residue leads to pollution issues related to NH -N and Mn. Although various methods exist to address the pollution caused by NH -N and Mn, existing hazard-free treatment methods do not consider the subsequent utilization of the electrolytic manganese residue. Meanwhile, resource recovery methods face challenges due to the complex salt structures present in electrolytic manganese residue.
View Article and Find Full Text PDFCureus
August 2025
Internal Medicine, Overlook Medical Center, Summit, USA.
Necrotizing autoimmune myopathy (NAM) is an uncommon inflammatory muscle disease marked by progressive weakness and elevated muscle enzymes. In some individuals, it may develop in association with statin use, particularly when specific autoantibodies are present. We report the case of a 65-year-old man who experienced worsening, painless proximal muscle weakness and significant creatine kinase (CK) elevation shortly after resuming statin therapy following a temporary discontinuation.
View Article and Find Full Text PDF